ABCC1 and acute myeloid leukemia: Moreover, three doxorubicin-resistant cell lines of acute myeloid leukemia were treated with resveratrol, and the results exhibited inhibition of cell growth, a significant reduction in MRP1 expression, and an increased uptake of the MRP1 substrate into the cells [128].